Dave joined T2 Biosystems in February 2019 and is the Vice President of Corporate Development. Prior to joining T2, Dave was a Senior Director at Huron Transaction Advisory (“HTA”), the investment banking arm of Huron Consulting Group, where he helped create the Life Sciences practice. While at HTA, he focused on strategic advisory, M&A, strategic partnerships and private placements for clinical diagnostics and drug discovery tools & services companies. From 2008 to 2016, he worked as a life sciences investment banker at Covington Associates in Boston where he served as a strategic advisor and helped execute M&A, strategic partnership and private placement transactions for emerging companies in the diagnostics, drug discovery tools and medical device sectors. Dave has a B.A. from Bowdoin College and earned his Ph.D. in molecular oncology & immunology from New York University School of Medicine.